Replacement techniques to reduce animal experiments in drug and nanoparticle development

Background Animals have been used for the testing of new drugs and nanoparticles to determine their safety and effectiveness before application in humans. Numerous drugs and nanoparticles have been developed through animal tests, and development in medical nanotechnology is progressing rapidly. Howe...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical investigation Vol. 50; no. 3; pp. 327 - 335
Main Authors Jin, Ik Sup, Yoon, Moon Sup, Park, Chun-Woong, Hong, Jin Tae, Chung, Youn Bok, Kim, Jin-Seok, Shin, Dae Hwan
Format Journal Article
LanguageEnglish
Published Singapore Springer Singapore 01.05.2020
한국약제학회
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Animals have been used for the testing of new drugs and nanoparticles to determine their safety and effectiveness before application in humans. Numerous drugs and nanoparticles have been developed through animal tests, and development in medical nanotechnology is progressing rapidly. However, a good experiment requires many animals. The primary measures to reduce animal experiments include reducing the number of animals used in each experiment and replacing laboratory animals with inanimate, cellular, or inferior animals to reduce sacrifices. Area covered Developing nanoparticles using simulations rather than experiments may be another alternative. Instead of animals, human cells or animal-derived organs, tissues, or cells could be used in experiments. These methods allow rapid toxicity and efficacy testing at low cost. However, the disadvantage of these methods is that they cannot accurately replicate the complex interrelationships between human organs, biological reactions to specific routes of administration, or toxicity of substances resulting from metabolic processes. To overcome these shortcomings of in vitro tests, new technologies such as organoids and organ-on-chips are progressing. These can be used to quickly examine the efficacy of newly developed drugs and nanoparticles and can be useful in developing patient-tailored agents. Expert opinion These technologies offer some promise but it is still difficult to entirely replace animal experiments. However, the scope of methods to replace experimental animals is widening, suggesting the potential to refine, reduce, and ultimately replace animal testing.
AbstractList Background Animals have been used for the testing of new drugs and nanoparticles to determine their safety and effectiveness before application in humans. Numerous drugs and nanoparticles have been developed through animal tests, and development in medical nanotechnology is progressing rapidly. However, a good experiment requires many animals. The primary measures to reduce animal experiments include reducing the number of animals used in each experiment and replacing laboratory animals with inanimate, cellular, or inferior animals to reduce sacrifices. Area covered Developing nanoparticles using simulations rather than experiments may be another alternative. Instead of animals, human cells or animal-derived organs, tissues, or cells could be used in experiments. These methods allow rapid toxicity and efficacy testing at low cost. However, the disadvantage of these methods is that they cannot accurately replicate the complex interrelationships between human organs, biological reactions to specific routes of administration, or toxicity of substances resulting from metabolic processes. To overcome these shortcomings of in vitro tests, new technologies such as organoids and organ-on-chips are progressing. These can be used to quickly examine the efficacy of newly developed drugs and nanoparticles and can be useful in developing patient-tailored agents. Expert opinion These technologies offer some promise but it is still difficult to entirely replace animal experiments. However, the scope of methods to replace experimental animals is widening, suggesting the potential to refine, reduce, and ultimately replace animal testing. KCI Citation Count: 4
Background Animals have been used for the testing of new drugs and nanoparticles to determine their safety and effectiveness before application in humans. Numerous drugs and nanoparticles have been developed through animal tests, and development in medical nanotechnology is progressing rapidly. However, a good experiment requires many animals. The primary measures to reduce animal experiments include reducing the number of animals used in each experiment and replacing laboratory animals with inanimate, cellular, or inferior animals to reduce sacrifices. Area covered Developing nanoparticles using simulations rather than experiments may be another alternative. Instead of animals, human cells or animal-derived organs, tissues, or cells could be used in experiments. These methods allow rapid toxicity and efficacy testing at low cost. However, the disadvantage of these methods is that they cannot accurately replicate the complex interrelationships between human organs, biological reactions to specific routes of administration, or toxicity of substances resulting from metabolic processes. To overcome these shortcomings of in vitro tests, new technologies such as organoids and organ-on-chips are progressing. These can be used to quickly examine the efficacy of newly developed drugs and nanoparticles and can be useful in developing patient-tailored agents. Expert opinion These technologies offer some promise but it is still difficult to entirely replace animal experiments. However, the scope of methods to replace experimental animals is widening, suggesting the potential to refine, reduce, and ultimately replace animal testing.
Author Jin, Ik Sup
Yoon, Moon Sup
Hong, Jin Tae
Chung, Youn Bok
Kim, Jin-Seok
Park, Chun-Woong
Shin, Dae Hwan
Author_xml – sequence: 1
  givenname: Ik Sup
  surname: Jin
  fullname: Jin, Ik Sup
  organization: College of Pharmacy, Chungbuk National University
– sequence: 2
  givenname: Moon Sup
  surname: Yoon
  fullname: Yoon, Moon Sup
  organization: College of Pharmacy, Chungbuk National University
– sequence: 3
  givenname: Chun-Woong
  surname: Park
  fullname: Park, Chun-Woong
  organization: College of Pharmacy, Chungbuk National University
– sequence: 4
  givenname: Jin Tae
  surname: Hong
  fullname: Hong, Jin Tae
  organization: College of Pharmacy, Chungbuk National University
– sequence: 5
  givenname: Youn Bok
  surname: Chung
  fullname: Chung, Youn Bok
  organization: College of Pharmacy, Chungbuk National University
– sequence: 6
  givenname: Jin-Seok
  surname: Kim
  fullname: Kim, Jin-Seok
  organization: Drug Information Research Institute, College of Pharmacy, Sookmyung Women’s University
– sequence: 7
  givenname: Dae Hwan
  surname: Shin
  fullname: Shin, Dae Hwan
  email: dshin@chungbuk.ac.kr
  organization: College of Pharmacy, Chungbuk National University
BackLink https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002587441$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kEtLAzEUhYNUsNb-AVfZuhjNYzKdLEvxUSgIpYK7kCZ36rTTZExmRP-9ace1q3PhfOfCOddo5LwDhG4puaeEzB5iTggRGWEkIyQvZ1l5gcaMSJ4VjOajv1sIwa7QNMY9OeEFLUs5Ru9raBtt4Aiuwx2YD1d_9hBx53EA2xvA2tVH3WD4biHUJyzi2mEb-l2yLHba-VaHrjYNYAtf0Pj2RN2gy0o3EaZ_OkFvT4-bxUu2en1eLuarzHAmuowzYw1jxVYDLywvk-SysBKY5oxbY2UhCPBkV7yY0aIShBoicl1JtqVbzifobvjrQqUOplZe12fdeXUIar7eLJVkkopcJpYNrAk-xgCValMlHX4UJeo0pRqmVGlKdZ5SlSnEh1BMsNtBUHvfB5c6_Zf6BT-YeX4
CitedBy_id crossref_primary_10_3390_pharmaceutics13111928
crossref_primary_10_1016_j_bios_2023_115100
crossref_primary_10_3390_pharmaceutics12060555
crossref_primary_10_4315_JFP_21_184
crossref_primary_10_1093_gigascience_giad049
crossref_primary_10_3390_pharmaceutics14071451
crossref_primary_10_1002_advs_202101437
crossref_primary_10_1371_journal_pone_0283825
Cites_doi 10.1517/17425255.2.6.875
10.1080/07853890310016333
10.1007/s40005-019-00434-2
10.1021/acs.jpcc.8b07616
10.1021/ac001132d
10.1016/j.addr.2006.09.011
10.1002/ppul.23773
10.2147/COPD.S62053
10.1016/j.ijpharm.2009.04.030
10.1016/j.cell.2014.08.016
10.1016/j.ijpharm.2017.01.006
10.1039/C7NR07898F
10.1016/j.jconrel.2014.08.027
10.1517/17425255.2012.648613
10.1063/1.2345914
10.1039/b504403k
10.1016/j.drudis.2011.10.023
10.2174/138161205774414510
10.1016/j.cell.2007.08.006
10.1038/s41598-017-02365-0
10.1080/10590501.2016.1166879
10.1016/j.nano.2009.06.001
10.1016/j.ces.2007.05.006
10.1063/1.3486610
10.1038/nrd4539
10.1038/ncomms14250
10.1016/j.stem.2013.11.002
10.1016/j.cbpa.2010.08.016
10.1021/ci5000467
10.1053/j.gastro.2011.07.050
10.1039/b901377f
10.1007/s11948-015-9659-8
10.1038/nnano.2012.168
10.1103/RevModPhys.77.977
10.1039/B711887B
10.1002/jbm.a.36305
10.1038/ncb3632
10.1126/science.1217815
10.1073/pnas.0915130107
10.1021/acs.chemrestox.5b00465
10.1517/17425247.2011.559457
10.1038/nbt.2989
10.1039/C0CS00003E
10.1021/acs.chemrestox.7b00083
10.1158/0008-5472.CAN-14-0663
10.1016/S0022-2836(65)80093-6
10.1016/j.biomaterials.2014.04.060
10.1038/nrm1858
10.1016/j.cell.2016.05.082
10.1038/nrd1032
10.1038/s41419-019-1453-0
10.1016/j.jconrel.2013.07.026
10.1038/nm.3973
10.1146/annurev-cellbio-101512-122340
10.1098/rsif.2017.0137
10.1039/C6IB00162A
10.1021/ac901560w
10.1039/b900912d
10.1146/annurev-bioeng-060418-052305
10.1038/s41467-019-11867-6
10.1021/acs.jcim.7b00244
10.1038/nrc1456
ContentType Journal Article
Copyright The Korean Society of Pharmaceutical Sciences and Technology 2020
Copyright_xml – notice: The Korean Society of Pharmaceutical Sciences and Technology 2020
DBID AAYXX
CITATION
ACYCR
DOI 10.1007/s40005-020-00487-8
DatabaseName CrossRef
Korean Citation Index
DatabaseTitle CrossRef
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
EISSN 2093-6214
EndPage 335
ExternalDocumentID oai_kci_go_kr_ARTI_9291549
10_1007_s40005_020_00487_8
GrantInformation_xml – fundername: National Research Foundation of Korea
  grantid: NRF-2019R1C1C1009996
– fundername: National Research Foundation (KR)
  grantid: MRC2017R1A5A2015541
GroupedDBID -EM
.UV
06D
0R~
0VY
203
29~
30V
4.4
406
408
96X
9ZL
AAAVM
AAFGU
AAHNG
AAIAL
AAJKR
AANXM
AANZL
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
AAZMS
ABDZT
ABECU
ABFGW
ABFTV
ABJNI
ABJOX
ABKAS
ABKCH
ABMQK
ABPLI
ABQBU
ABTEG
ABTHY
ABTKH
ABTMW
ABXPI
ACBMV
ACBRV
ACBYP
ACCUX
ACGFS
ACHSB
ACIGE
ACIPQ
ACKNC
ACMLO
ACOKC
ACTTH
ACVWB
ACWMK
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFTE
AEGNC
AEJHL
AEJRE
AEOHA
AEPYU
AESKC
AESTI
AETCA
AEVLU
AEVTX
AEXYK
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGMZJ
AGQMX
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKLTO
AKMHD
AKQUC
ALFXC
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMXSW
AMYLF
AMYQR
ANMIH
AUKKA
AXYYD
BGNMA
CSCUP
DNIVK
DPUIP
EBLON
EBS
EIOEI
EJD
ESBYG
FERAY
FIGPU
FINBP
FNLPD
FRP
FRRFC
FSGXE
FYJPI
GGCAI
GGRSB
GJIRD
GQ6
GQ7
HMJXF
HRMNR
HZ~
I0C
IKXTQ
IWAJR
IXD
J-C
JBSCW
JDI
JZLTJ
KOV
LLZTM
M4Y
NPVJJ
NQJWS
NU0
O9-
O9J
PT4
RLLFE
RSV
S3A
SBL
SHX
SISQX
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
TSG
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
Z7U
Z87
ZMTXR
ZOVNA
~A9
AACDK
AAJBT
AASML
AAYXX
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
CITATION
ROL
SJYHP
ACYCR
ID FETCH-LOGICAL-c325t-32cdc226bae36d38ae3496d9e2a323dcd9650e3baef36716f501c054af92b1b33
IEDL.DBID AGYKE
ISSN 2093-5552
IngestDate Tue Nov 21 21:39:31 EST 2023
Thu Sep 12 18:26:33 EDT 2024
Sat Dec 16 12:10:47 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Organoid
Animal ethics
Drug development
Nanoparticle
Animal experiment replacement
Biochip
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c325t-32cdc226bae36d38ae3496d9e2a323dcd9650e3baef36716f501c054af92b1b33
PageCount 9
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_9291549
crossref_primary_10_1007_s40005_020_00487_8
springer_journals_10_1007_s40005_020_00487_8
PublicationCentury 2000
PublicationDate 2020-05-01
PublicationDateYYYYMMDD 2020-05-01
PublicationDate_xml – month: 05
  year: 2020
  text: 2020-05-01
  day: 01
PublicationDecade 2020
PublicationPlace Singapore
PublicationPlace_xml – name: Singapore
PublicationTitle Journal of pharmaceutical investigation
PublicationTitleAbbrev J. Pharm. Investig
PublicationYear 2020
Publisher Springer Singapore
한국약제학회
Publisher_xml – name: Springer Singapore
– name: 한국약제학회
References Kim, Lee, Pyo, Tran, Park (CR31) 2020; 50
Sekine, Yanagibori, Suzuki, Sugiyama, Yamaji, Ishibashi, Fujisawa (CR50) 2014; 9
Kwak, Ozcelikkale, Shin, Park, Han (CR33) 2014; 194
Astashkina, Jones, Thiagarajan, Kurtzeborn, Ghandehari, Brooks, Grainger (CR2) 2014; 35
Wei, Hao, Yuan, Li, Juan, Sha, Fang (CR59) 2009; 376
Van De Waterbeemd, Gifford (CR57) 2003; 2
Yang, Li, Wu, Li, Liu, Tang (CR63) 2017; 30
Valencia, Farokhzad, Karnik, Langer (CR56) 2012; 7
Walsh, Cook, Sanders, Aurisicchio, Ciliberto, Arteaga, Skala (CR58) 2014; 74
Batrakova, Gendelman, Kabanov (CR4) 2011; 8
Moroy, Martiny, Vayer, Villoutreix, Miteva (CR41) 2012; 17
Li, Chen, Cheng, Wu, Bian, Xu, Li, Liu, Shen, Tang (CR34) 2014; 54
Mulliner, Schmidt, Stolte, Spirkl, Czich, Amberg (CR43) 2016; 29
Gupta, Rai (CR23) 2018; 10
Sato, Stange, Ferrante, Vries, Van Es, Van Den Brink, Van Houdt, Pronk, Van Gorp, Siersema, Clevers (CR47) 2011; 141
Esch, Bahinski, Huh (CR15) 2015; 14
Heldin, Rubin, Pietras, Stman (CR24) 2004; 4
Cruz-Acuna, Quiros, Farkas, Dedhia, Huang, Siuda, Garcia-Hernandez, Miller, Spence, Nusrat, Garcia (CR9) 2017; 19
Davoudi, Peroutka-Bigus, Bellaire, Wannemuehler, Barrett, Narasimhan, Wang (CR12) 2018; 106
Korin, Kanapathipillai, Matthews, Crescente, Brill, Mammoto, Ghosh, Jurek, Bencherif, Bhatta, Coskun, Feldman, Wagner, Ingber (CR32) 2012; 337
CR42
Golbamaki, Benfenati, Golbamaki, Manganaro, Merdivan, Roncaglioni, Gini (CR19) 2016; 34
Mahto, Yoon, Rhee (CR37) 2010; 4
Curzer, Perry, Wallace, Perry (CR10) 2016; 22
Keenan, Hsu, Folch (CR29) 2006; 89
Ehrlich, Duche, Ouedraogo, Nahmias (CR14) 2019; 21
Flaim, Chien, Bhatia (CR17) 2005; 2
Yamada, Cukierman (CR62) 2007; 130
Abu Lila, Kiwada, Ishida (CR1) 2013; 172
Przybylak, Cronin (CR46) 2012; 8
Zhang, Ai, Chen, Yin, Hu, Zhu, Zhao, Zhao, Liu (CR66) 2017; 7
Blais, Rawls, Dougherty, Li, Kolling, Ye, Wallqvist, Papin (CR6) 2017; 8
Wlodkowic, Cooper (CR60) 2010; 14
Ingber (CR27) 2003; 35
Lunnoo, Assawakhajornsak, Puangmali (CR36) 2019; 123
Bhatia, Ingber (CR5) 2014; 32
Li, Guo, Yu, Xu, Xu, Qin (CR35) 2016; 8
Chou, Ming, Chan (CR7) 2011; 40
Farokhzad, Langer (CR16) 2006; 58
Ploss, Khetani, Jones, Syder, Trehan, Gaysinskaya, Mu, Ritola, Rice, Bhatia (CR45) 2010; 107
Xu, Pei, Lai (CR61) 2017; 57
Huang, Holtzinger, Jagan, Begora, Lohse, Ngai, Nostro, Wang, Muthuswamy, Crawford, Arrowsmith, Kalloger, Renouf, Connor, Cleary, Schaeffer, Roehrl, Tsao, Gallinger, Keller, Muthuswamy (CR26) 2015; 21
Griffith, Swartz (CR21) 2006; 7
Clevers (CR8) 2016; 165
Schuster, Laggner, Langer (CR48) 2005; 11
Tsai, Trubelja, Shen, Bao (CR55) 2017; 14
Squires, Quake (CR52) 2005; 77
Yu, Meyvantsson, Shkel, Beebe (CR65) 2005; 5
Keenan, Folch (CR28) 2008; 8
Davidson, Harvie (CR11) 2007; 62
Murday, Siegel, Stein, Wright (CR44) 2009; 5
Dertinger, Chiu, Jeon, Whitesides (CR13) 2001; 73
Mannino, Homa, Akinbami, Ford, Redd (CR39) 2002; 51
Schwank, Koo, Sasselli, Dekkers, Heo, Demircan, Sasaki, Boymans, Cuppen, Van der Ent, Nieuwenhuis, Beekman, Clevers (CR49) 2013; 13
Sung, Shuler (CR53) 2009; 9
Gao, Vela, Sboner, Iaquinta, Karthaus, Gopalan, Dowling, Wanjala, Undvall, Arora, Wongvipat, Kossai, Ramazanoglu, Barboza, Di, Cao, Zhang, Sirota, Ran, Macdonald, Beltran, Mosquera, Touijer, Scardino, Laudone, Curtis, Rathkopf, Morris, Danila, Slovin, Solomon, Eastham, Chi, Carver, Rubin, Scher, Clevers, Sawyers, Chen (CR18) 2014; 159
CR25
Martignoni, Groothuis, De Kanter (CR40) 2006; 2
Shin, Kwon (CR51) 2017; 518
Guimbellot, Sharma, Rowe (CR22) 2017; 52
Mammoto, Mammoto, Ingber (CR38) 2013; 29
Kim, Mun, Sung, Cho, Jeon, Chun, Jung, Shin, Jeong, Kim, Choi, Jeong, Taylor, Jain, Meyerson, Jang (CR30) 2019; 10
Grassi, Alfonsi, Francescangeli, Signore, De Angelis, Addario, Costantini, Flex, Ciolfi, Pizzi, Bruselles, Pallocca, Simone, Haoui, Falchi, Milella, Sentinelli, Di Matteo, Stellacci, Gallucci, Muto, Tartaglia, De Maria, Bonci (CR20) 2019; 10
Young, Watson, Srigunapalan, Wheeler, Simmons (CR64) 2010; 82
Toh, Lim, Tai, Xiao, Van Noort, Yu (CR54) 2009; 9
Bangham, Standish, Watkins (CR3) 1965; 13
J Guimbellot (487_CR22) 2017; 52
DM Mannino (487_CR39) 2002; 51
EW Esch (487_CR15) 2015; 14
D-H Kim (487_CR31) 2020; 50
Z Wei (487_CR59) 2009; 376
R Gupta (487_CR23) 2018; 10
A Ploss (487_CR45) 2010; 107
Y Xu (487_CR61) 2017; 57
J Murday (487_CR44) 2009; 5
G Schwank (487_CR49) 2013; 13
HJ Curzer (487_CR10) 2016; 22
OC Farokhzad (487_CR16) 2006; 58
M Kim (487_CR30) 2019; 10
PM Valencia (487_CR56) 2012; 7
LYT Chou (487_CR7) 2011; 40
L Grassi (487_CR20) 2019; 10
487_CR25
T Sato (487_CR47) 2011; 141
AD Bangham (487_CR3) 1965; 13
AJ Walsh (487_CR58) 2014; 74
D Gao (487_CR18) 2014; 159
H Yang (487_CR63) 2017; 30
TM Keenan (487_CR28) 2008; 8
H Yu (487_CR65) 2005; 5
AS Abu Lila (487_CR1) 2013; 172
Y Sekine (487_CR50) 2014; 9
SK Mahto (487_CR37) 2010; 4
TM Keenan (487_CR29) 2006; 89
H Van De Waterbeemd (487_CR57) 2003; 2
SKW Dertinger (487_CR13) 2001; 73
A Golbamaki (487_CR19) 2016; 34
JH Sung (487_CR53) 2009; 9
Y-C Toh (487_CR54) 2009; 9
M Martignoni (487_CR40) 2006; 2
R Cruz-Acuna (487_CR9) 2017; 19
KR Przybylak (487_CR46) 2012; 8
EV Batrakova (487_CR4) 2011; 8
G Moroy (487_CR41) 2012; 17
LG Griffith (487_CR21) 2006; 7
MR Davidson (487_CR11) 2007; 62
Z Davoudi (487_CR12) 2018; 106
T Lunnoo (487_CR36) 2019; 123
TM Squires (487_CR52) 2005; 77
D Ingber (487_CR27) 2003; 35
X Li (487_CR34) 2014; 54
KM Yamada (487_CR62) 2007; 130
D Mulliner (487_CR43) 2016; 29
C-H Heldin (487_CR24) 2004; 4
A Ehrlich (487_CR14) 2019; 21
EWK Young (487_CR64) 2010; 82
CJ Flaim (487_CR17) 2005; 2
SN Bhatia (487_CR5) 2014; 32
N Korin (487_CR32) 2012; 337
Z Li (487_CR35) 2016; 8
D Wlodkowic (487_CR60) 2010; 14
L Huang (487_CR26) 2015; 21
487_CR42
L Zhang (487_CR66) 2017; 7
H-F Tsai (487_CR55) 2017; 14
AI Astashkina (487_CR2) 2014; 35
T Mammoto (487_CR38) 2013; 29
EM Blais (487_CR6) 2017; 8
B Kwak (487_CR33) 2014; 194
DH Shin (487_CR51) 2017; 518
H Clevers (487_CR8) 2016; 165
D Schuster (487_CR48) 2005; 11
References_xml – volume: 40
  start-page: 233
  year: 2011
  end-page: 245
  ident: CR7
  article-title: Strategies for the intracellular delivery of nanoparticles
  publication-title: Chem Soc Rev
  contributor:
    fullname: Chan
– volume: 17
  start-page: 44
  year: 2012
  end-page: 55
  ident: CR41
  article-title: Toward in silico structure-based ADMET prediction in drug discovery
  publication-title: Drug Discov Today
  contributor:
    fullname: Miteva
– volume: 30
  start-page: 1355
  year: 2017
  end-page: 1364
  ident: CR63
  article-title: Evaluation of different methods for identification of structural alerts using chemical ames mutagenicity data set as a benchmark
  publication-title: Chem Res Toxicol
  contributor:
    fullname: Tang
– volume: 29
  start-page: 757
  year: 2016
  end-page: 767
  ident: CR43
  article-title: Computational models for human and animal hepatotoxicity with a global application scope
  publication-title: Em Res Toxicol
  contributor:
    fullname: Amberg
– volume: 62
  start-page: 4229
  year: 2007
  end-page: 4240
  ident: CR11
  article-title: Electroviscous effects in low Reynolds number liquid flow through a slit-like microfluidic contraction
  publication-title: Chem Eng Sci
  contributor:
    fullname: Harvie
– volume: 13
  start-page: 238
  year: 1965
  ident: CR3
  article-title: Diffusion of univalent ions across the lamellae of swollen phospholipids
  publication-title: J Mol Biol
  contributor:
    fullname: Watkins
– volume: 2
  start-page: 875
  year: 2006
  end-page: 894
  ident: CR40
  article-title: Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction
  publication-title: Expert Opin Drug Metab Toxicol
  contributor:
    fullname: De Kanter
– volume: 8
  start-page: 14250
  year: 2017
  ident: CR6
  article-title: Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions
  publication-title: Nat Commun
  contributor:
    fullname: Papin
– volume: 10
  start-page: 3991
  year: 2019
  ident: CR30
  article-title: Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
  publication-title: Nat Commun
  contributor:
    fullname: Jang
– volume: 32
  start-page: 760
  year: 2014
  end-page: 772
  ident: CR5
  article-title: Microfluidic organs-on-chips
  publication-title: Nat Biotechnol
  contributor:
    fullname: Ingber
– volume: 54
  start-page: 1061
  year: 2014
  end-page: 1069
  ident: CR34
  article-title: In silico prediction of chemical acute oral toxicity using multi-classification methods
  publication-title: J Chem Inf Model
  contributor:
    fullname: Tang
– volume: 82
  start-page: 808
  year: 2010
  end-page: 816
  ident: CR64
  article-title: Technique for real-time measurements of endothelial permeability in a microfluidic membrane chip using laser-induced fluorescence detection
  publication-title: Anal Chem
  contributor:
    fullname: Simmons
– volume: 7
  start-page: 211
  year: 2006
  end-page: 224
  ident: CR21
  article-title: Capturing complex 3D tissue physiology in vitro
  publication-title: Nat Rev Mol Cell Biol
  contributor:
    fullname: Swartz
– ident: CR25
– volume: 50
  start-page: 17
  year: 2020
  end-page: 27
  ident: CR31
  article-title: Solubility enhancement and application of cyclodextrins in local drug delivery
  publication-title: J Pharm Investig
  contributor:
    fullname: Park
– volume: 5
  start-page: 251
  year: 2009
  end-page: 273
  ident: CR44
  article-title: Translational nanomedicine: status assessment and opportunities
  publication-title: Nanomedicine
  contributor:
    fullname: Wright
– volume: 21
  start-page: 1364
  year: 2015
  end-page: 1371
  ident: CR26
  article-title: Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids
  publication-title: Nat Med
  contributor:
    fullname: Muthuswamy
– volume: 51
  start-page: 1
  year: 2002
  end-page: 16
  ident: CR39
  article-title: Chronic obstructive pulmonary disease surveillance—United States, 1971–2000
  publication-title: Respir Care.
  contributor:
    fullname: Redd
– ident: CR42
– volume: 8
  start-page: 1022
  year: 2016
  end-page: 1029
  ident: CR35
  article-title: Assessment of metabolism-dependent drug efficacy and toxicity on a multilayer organs-on-a-chip
  publication-title: Int J Integr Biol
  contributor:
    fullname: Qin
– volume: 7
  start-page: 623
  year: 2012
  end-page: 629
  ident: CR56
  article-title: Microfluidic technologies for accelerating the clinical translation of nanoparticles
  publication-title: Nat Nanotechnol
  contributor:
    fullname: Langer
– volume: 337
  start-page: 738
  year: 2012
  end-page: 742
  ident: CR32
  article-title: Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels
  publication-title: Science
  contributor:
    fullname: Ingber
– volume: 35
  start-page: 6323
  year: 2014
  end-page: 6331
  ident: CR2
  article-title: Nanoparticle toxicity assessment using an in vitro 3-D kidney organoid culture model
  publication-title: Biomaterials
  contributor:
    fullname: Grainger
– volume: 130
  start-page: 601
  year: 2007
  end-page: 610
  ident: CR62
  article-title: Modeling tissue morphogenesis and cancer in 3D
  publication-title: Cell
  contributor:
    fullname: Cukierman
– volume: 34
  start-page: 97
  year: 2016
  end-page: 113
  ident: CR19
  article-title: New clues on carcinogenicity-related substructures derived from mining two large datasets of chemical compounds
  publication-title: J Environ Sciheal C
  contributor:
    fullname: Gini
– volume: 4
  start-page: 034111
  year: 2010
  ident: CR37
  article-title: A new perspective on in vitro assessment method for evaluating quantum dot toxicity by using microfluidics technology
  publication-title: Biomicrofluidics
  contributor:
    fullname: Rhee
– volume: 13
  start-page: 653
  year: 2013
  end-page: 658
  ident: CR49
  article-title: Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients
  publication-title: Cell Stem Cell
  contributor:
    fullname: Clevers
– volume: 165
  start-page: 1586
  year: 2016
  end-page: 1597
  ident: CR8
  article-title: Modeling development and disease with organoids
  publication-title: Cell
  contributor:
    fullname: Clevers
– volume: 106
  start-page: 876
  year: 2018
  end-page: 886
  ident: CR12
  article-title: Intestinal organoids containing poly(lactic-co-glycolic acid) nanoparticles for the treatment of inflammatory bowel diseases
  publication-title: J Biomed Mater Res A
  contributor:
    fullname: Wang
– volume: 4
  start-page: 806
  year: 2004
  end-page: 813
  ident: CR24
  article-title: High interstitial fluid pressure—an obstacle in cancer therapy
  publication-title: Nat Rev Cancer
  contributor:
    fullname: Stman
– volume: 22
  start-page: 549
  year: 2016
  end-page: 565
  ident: CR10
  article-title: The three Rs of animal research: what they mean for the institutional animal care and use committee and why
  publication-title: Sci Eng Ethics
  contributor:
    fullname: Perry
– volume: 376
  start-page: 176
  year: 2009
  end-page: 185
  ident: CR59
  article-title: Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: Formulation, optimization and in vitro characterization
  publication-title: Int J Pharm
  contributor:
    fullname: Fang
– volume: 14
  start-page: 556
  year: 2010
  end-page: 567
  ident: CR60
  article-title: Tumors on chips: oncology meets microfluidics
  publication-title: Curr Opin Chem Biol
  contributor:
    fullname: Cooper
– volume: 8
  start-page: 201
  year: 2012
  end-page: 217
  ident: CR46
  article-title: In silico models for drug-induced liver injury—current status
  publication-title: Expert Opin Drug Metab Toxicol
  contributor:
    fullname: Cronin
– volume: 5
  start-page: 1089
  year: 2005
  end-page: 1095
  ident: CR65
  article-title: Diffusion dependent cell behavior in microenvironments
  publication-title: Lab Chip
  contributor:
    fullname: Beebe
– volume: 9
  start-page: 2026
  year: 2009
  end-page: 2035
  ident: CR54
  article-title: A microfluidic 3D hepatocyte chip for drug toxicity testing
  publication-title: Lab Chip
  contributor:
    fullname: Yu
– volume: 172
  start-page: 38
  year: 2013
  end-page: 47
  ident: CR1
  article-title: The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage
  publication-title: J Control Release
  contributor:
    fullname: Ishida
– volume: 159
  start-page: 176
  year: 2014
  end-page: 187
  ident: CR18
  article-title: Organoid cultures derived from patients with advanced prostate cancer
  publication-title: Cell
  contributor:
    fullname: Chen
– volume: 73
  start-page: 1240
  year: 2001
  end-page: 1246
  ident: CR13
  article-title: Generation of gradients having complex shapes using microfluidic networks
  publication-title: Anal Chem
  contributor:
    fullname: Whitesides
– volume: 194
  start-page: 157
  year: 2014
  end-page: 167
  ident: CR33
  article-title: Simulation of complex transport of nanoparticles around a tumor using tumor-microenvironment-on-chip
  publication-title: J Control Release
  contributor:
    fullname: Han
– volume: 9
  start-page: 647
  year: 2014
  end-page: 656
  ident: CR50
  article-title: Surveillance of chronic obstructive pulmonary disease in high-risk individuals by using regional lung cancer mass screening
  publication-title: Int J Chron Obstruct Pulmon Dis
  contributor:
    fullname: Fujisawa
– volume: 14
  start-page: 20170137
  year: 2017
  ident: CR55
  article-title: Tumour-on-a-chip: Microfluidic models of tumour morphology, growth and microenvironment
  publication-title: J R Soc Interface
  contributor:
    fullname: Bao
– volume: 7
  start-page: 2118
  year: 2017
  ident: CR66
  article-title: CarcinoPred-EL: Novel models for predicting the carcinogenicity of chemicals using molecular fingerprints and ensemble learning methods
  publication-title: Sci Rep
  contributor:
    fullname: Liu
– volume: 58
  start-page: 1456
  year: 2006
  end-page: 1459
  ident: CR16
  article-title: Nanomedicine: Developing smarter therapeutic and diagnostic modalities
  publication-title: Adv Drug Deliv Rev
  contributor:
    fullname: Langer
– volume: 141
  start-page: 1762
  year: 2011
  end-page: 1772
  ident: CR47
  article-title: Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium
  publication-title: Gastroenterology
  contributor:
    fullname: Clevers
– volume: 10
  start-page: 4940
  year: 2018
  end-page: 4951
  ident: CR23
  article-title: In-silico design of nanoparticles for transdermal drug delivery application
  publication-title: Nanoscale
  contributor:
    fullname: Rai
– volume: 11
  start-page: 3545
  year: 2005
  end-page: 3559
  ident: CR48
  article-title: Why drugs fail—a study on side effects in new chemical entities
  publication-title: Curr Pharm Des
  contributor:
    fullname: Langer
– volume: 35
  start-page: 564
  year: 2003
  end-page: 577
  ident: CR27
  article-title: Mechanobiology and diseases of mechanotransduction
  publication-title: Ann Med
  contributor:
    fullname: Ingber
– volume: 29
  start-page: 27
  year: 2013
  end-page: 61
  ident: CR38
  article-title: Mechanobiology and developmental control
  publication-title: Annu Rev Cell Dev Biol
  contributor:
    fullname: Ingber
– volume: 518
  start-page: 307
  year: 2017
  end-page: 311
  ident: CR51
  article-title: Epothilone B-based 3-in-1 polymeric micelle for anticancer drug therapy
  publication-title: Int J Pharm
  contributor:
    fullname: Kwon
– volume: 19
  start-page: 1326
  year: 2017
  end-page: 1335
  ident: CR9
  article-title: Synthetic hydrogels for human intestinal organoid generation and colonic wound repair
  publication-title: Nat Cell Biol
  contributor:
    fullname: Garcia
– volume: 10
  start-page: 201
  year: 2019
  ident: CR20
  article-title: Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases
  publication-title: Cell Death Dis
  contributor:
    fullname: Bonci
– volume: 8
  start-page: 415
  year: 2011
  end-page: 433
  ident: CR4
  article-title: Cell-mediated drug delivery
  publication-title: Expert Opin Drug Deliv
  contributor:
    fullname: Kabanov
– volume: 52
  start-page: S4
  year: 2017
  end-page: S14
  ident: CR22
  article-title: Toward inclusive therapy with CFTR modulators: progress and challenges
  publication-title: Pediatric Pulm
  contributor:
    fullname: Rowe
– volume: 57
  start-page: 2672
  year: 2017
  end-page: 2685
  ident: CR61
  article-title: Deep learning based regression and multiclass models for acute oral toxicity prediction with automatic chemical feature extraction
  publication-title: J Chem Inf Model
  contributor:
    fullname: Lai
– volume: 14
  start-page: 248
  year: 2015
  end-page: 260
  ident: CR15
  article-title: Organs-on-chips at the frontiers of drug discovery
  publication-title: Nat Rev Drug Discov
  contributor:
    fullname: Huh
– volume: 2
  start-page: 192
  year: 2003
  end-page: 204
  ident: CR57
  article-title: ADMET in silico modelling: towards prediction paradise?
  publication-title: Nat Rev Drug Discov
  contributor:
    fullname: Gifford
– volume: 2
  start-page: 119
  year: 2005
  end-page: 125
  ident: CR17
  article-title: An extracellular matrix microarray for probing cellular differentiation
  publication-title: Nat Med
  contributor:
    fullname: Bhatia
– volume: 8
  start-page: 34
  year: 2008
  end-page: 57
  ident: CR28
  article-title: Biomolecular gradients in cell culture systems
  publication-title: Lab Chip
  contributor:
    fullname: Folch
– volume: 74
  start-page: 5184
  year: 2014
  end-page: 5194
  ident: CR58
  article-title: Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer
  publication-title: Cancer Res
  contributor:
    fullname: Skala
– volume: 89
  start-page: 114103
  year: 2006
  ident: CR29
  article-title: Microfluidic “jets” for generating steady-state gradients of soluble molecules on open surfaces
  publication-title: Appl Phys Lett
  contributor:
    fullname: Folch
– volume: 21
  start-page: 219
  year: 2019
  end-page: 239
  ident: CR14
  article-title: Challenges and opportunities in the design of liver-on-chip microdevices
  publication-title: Annu Rev Biomed Eng
  contributor:
    fullname: Nahmias
– volume: 107
  start-page: 3141
  year: 2010
  end-page: 3145
  ident: CR45
  article-title: Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
  publication-title: Proc Natl Acad Sci
  contributor:
    fullname: Bhatia
– volume: 9
  start-page: 1385
  year: 2009
  end-page: 1394
  ident: CR53
  article-title: A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs
  publication-title: Lab Chip
  contributor:
    fullname: Shuler
– volume: 123
  start-page: 3801
  year: 2019
  end-page: 3810
  ident: CR36
  article-title: In silico study of gold nanoparticle uptake into a mammalian cell: interplay of size, shape, surface charge, and aggregation
  publication-title: J Phys Chem C
  contributor:
    fullname: Puangmali
– volume: 77
  start-page: 977
  year: 2005
  end-page: 1026
  ident: CR52
  article-title: Microfluidics: Fluid physics at the nanoliter scale
  publication-title: Rev Mod Phys
  contributor:
    fullname: Quake
– volume: 2
  start-page: 875
  year: 2006
  ident: 487_CR40
  publication-title: Expert Opin Drug Metab Toxicol
  doi: 10.1517/17425255.2.6.875
  contributor:
    fullname: M Martignoni
– volume: 35
  start-page: 564
  year: 2003
  ident: 487_CR27
  publication-title: Ann Med
  doi: 10.1080/07853890310016333
  contributor:
    fullname: D Ingber
– volume: 50
  start-page: 17
  year: 2020
  ident: 487_CR31
  publication-title: J Pharm Investig
  doi: 10.1007/s40005-019-00434-2
  contributor:
    fullname: D-H Kim
– volume: 123
  start-page: 3801
  year: 2019
  ident: 487_CR36
  publication-title: J Phys Chem C
  doi: 10.1021/acs.jpcc.8b07616
  contributor:
    fullname: T Lunnoo
– volume: 73
  start-page: 1240
  year: 2001
  ident: 487_CR13
  publication-title: Anal Chem
  doi: 10.1021/ac001132d
  contributor:
    fullname: SKW Dertinger
– volume: 58
  start-page: 1456
  year: 2006
  ident: 487_CR16
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2006.09.011
  contributor:
    fullname: OC Farokhzad
– volume: 52
  start-page: S4
  year: 2017
  ident: 487_CR22
  publication-title: Pediatric Pulm
  doi: 10.1002/ppul.23773
  contributor:
    fullname: J Guimbellot
– volume: 9
  start-page: 647
  year: 2014
  ident: 487_CR50
  publication-title: Int J Chron Obstruct Pulmon Dis
  doi: 10.2147/COPD.S62053
  contributor:
    fullname: Y Sekine
– volume: 376
  start-page: 176
  year: 2009
  ident: 487_CR59
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2009.04.030
  contributor:
    fullname: Z Wei
– volume: 159
  start-page: 176
  year: 2014
  ident: 487_CR18
  publication-title: Cell
  doi: 10.1016/j.cell.2014.08.016
  contributor:
    fullname: D Gao
– volume: 518
  start-page: 307
  year: 2017
  ident: 487_CR51
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2017.01.006
  contributor:
    fullname: DH Shin
– volume: 10
  start-page: 4940
  year: 2018
  ident: 487_CR23
  publication-title: Nanoscale
  doi: 10.1039/C7NR07898F
  contributor:
    fullname: R Gupta
– volume: 194
  start-page: 157
  year: 2014
  ident: 487_CR33
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2014.08.027
  contributor:
    fullname: B Kwak
– volume: 8
  start-page: 201
  year: 2012
  ident: 487_CR46
  publication-title: Expert Opin Drug Metab Toxicol
  doi: 10.1517/17425255.2012.648613
  contributor:
    fullname: KR Przybylak
– volume: 89
  start-page: 114103
  year: 2006
  ident: 487_CR29
  publication-title: Appl Phys Lett
  doi: 10.1063/1.2345914
  contributor:
    fullname: TM Keenan
– volume: 5
  start-page: 1089
  year: 2005
  ident: 487_CR65
  publication-title: Lab Chip
  doi: 10.1039/b504403k
  contributor:
    fullname: H Yu
– volume: 2
  start-page: 119
  year: 2005
  ident: 487_CR17
  publication-title: Nat Med
  contributor:
    fullname: CJ Flaim
– volume: 17
  start-page: 44
  year: 2012
  ident: 487_CR41
  publication-title: Drug Discov Today
  doi: 10.1016/j.drudis.2011.10.023
  contributor:
    fullname: G Moroy
– volume: 11
  start-page: 3545
  year: 2005
  ident: 487_CR48
  publication-title: Curr Pharm Des
  doi: 10.2174/138161205774414510
  contributor:
    fullname: D Schuster
– volume: 130
  start-page: 601
  year: 2007
  ident: 487_CR62
  publication-title: Cell
  doi: 10.1016/j.cell.2007.08.006
  contributor:
    fullname: KM Yamada
– volume: 7
  start-page: 2118
  year: 2017
  ident: 487_CR66
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-02365-0
  contributor:
    fullname: L Zhang
– volume: 34
  start-page: 97
  year: 2016
  ident: 487_CR19
  publication-title: J Environ Sciheal C
  doi: 10.1080/10590501.2016.1166879
  contributor:
    fullname: A Golbamaki
– volume: 5
  start-page: 251
  year: 2009
  ident: 487_CR44
  publication-title: Nanomedicine
  doi: 10.1016/j.nano.2009.06.001
  contributor:
    fullname: J Murday
– volume: 62
  start-page: 4229
  year: 2007
  ident: 487_CR11
  publication-title: Chem Eng Sci
  doi: 10.1016/j.ces.2007.05.006
  contributor:
    fullname: MR Davidson
– volume: 4
  start-page: 034111
  year: 2010
  ident: 487_CR37
  publication-title: Biomicrofluidics
  doi: 10.1063/1.3486610
  contributor:
    fullname: SK Mahto
– volume: 14
  start-page: 248
  year: 2015
  ident: 487_CR15
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd4539
  contributor:
    fullname: EW Esch
– volume: 8
  start-page: 14250
  year: 2017
  ident: 487_CR6
  publication-title: Nat Commun
  doi: 10.1038/ncomms14250
  contributor:
    fullname: EM Blais
– volume: 13
  start-page: 653
  year: 2013
  ident: 487_CR49
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2013.11.002
  contributor:
    fullname: G Schwank
– volume: 14
  start-page: 556
  year: 2010
  ident: 487_CR60
  publication-title: Curr Opin Chem Biol
  doi: 10.1016/j.cbpa.2010.08.016
  contributor:
    fullname: D Wlodkowic
– volume: 54
  start-page: 1061
  year: 2014
  ident: 487_CR34
  publication-title: J Chem Inf Model
  doi: 10.1021/ci5000467
  contributor:
    fullname: X Li
– volume: 141
  start-page: 1762
  year: 2011
  ident: 487_CR47
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2011.07.050
  contributor:
    fullname: T Sato
– volume: 9
  start-page: 1385
  year: 2009
  ident: 487_CR53
  publication-title: Lab Chip
  doi: 10.1039/b901377f
  contributor:
    fullname: JH Sung
– volume: 51
  start-page: 1
  year: 2002
  ident: 487_CR39
  publication-title: Respir Care.
  contributor:
    fullname: DM Mannino
– volume: 22
  start-page: 549
  year: 2016
  ident: 487_CR10
  publication-title: Sci Eng Ethics
  doi: 10.1007/s11948-015-9659-8
  contributor:
    fullname: HJ Curzer
– volume: 7
  start-page: 623
  year: 2012
  ident: 487_CR56
  publication-title: Nat Nanotechnol
  doi: 10.1038/nnano.2012.168
  contributor:
    fullname: PM Valencia
– volume: 77
  start-page: 977
  year: 2005
  ident: 487_CR52
  publication-title: Rev Mod Phys
  doi: 10.1103/RevModPhys.77.977
  contributor:
    fullname: TM Squires
– volume: 8
  start-page: 34
  year: 2008
  ident: 487_CR28
  publication-title: Lab Chip
  doi: 10.1039/B711887B
  contributor:
    fullname: TM Keenan
– volume: 106
  start-page: 876
  year: 2018
  ident: 487_CR12
  publication-title: J Biomed Mater Res A
  doi: 10.1002/jbm.a.36305
  contributor:
    fullname: Z Davoudi
– volume: 19
  start-page: 1326
  year: 2017
  ident: 487_CR9
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb3632
  contributor:
    fullname: R Cruz-Acuna
– volume: 337
  start-page: 738
  year: 2012
  ident: 487_CR32
  publication-title: Science
  doi: 10.1126/science.1217815
  contributor:
    fullname: N Korin
– volume: 107
  start-page: 3141
  year: 2010
  ident: 487_CR45
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.0915130107
  contributor:
    fullname: A Ploss
– volume: 29
  start-page: 757
  year: 2016
  ident: 487_CR43
  publication-title: Em Res Toxicol
  doi: 10.1021/acs.chemrestox.5b00465
  contributor:
    fullname: D Mulliner
– volume: 8
  start-page: 415
  year: 2011
  ident: 487_CR4
  publication-title: Expert Opin Drug Deliv
  doi: 10.1517/17425247.2011.559457
  contributor:
    fullname: EV Batrakova
– volume: 32
  start-page: 760
  year: 2014
  ident: 487_CR5
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2989
  contributor:
    fullname: SN Bhatia
– volume: 40
  start-page: 233
  year: 2011
  ident: 487_CR7
  publication-title: Chem Soc Rev
  doi: 10.1039/C0CS00003E
  contributor:
    fullname: LYT Chou
– volume: 30
  start-page: 1355
  year: 2017
  ident: 487_CR63
  publication-title: Chem Res Toxicol
  doi: 10.1021/acs.chemrestox.7b00083
  contributor:
    fullname: H Yang
– volume: 74
  start-page: 5184
  year: 2014
  ident: 487_CR58
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-14-0663
  contributor:
    fullname: AJ Walsh
– volume: 13
  start-page: 238
  year: 1965
  ident: 487_CR3
  publication-title: J Mol Biol
  doi: 10.1016/S0022-2836(65)80093-6
  contributor:
    fullname: AD Bangham
– volume: 35
  start-page: 6323
  year: 2014
  ident: 487_CR2
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2014.04.060
  contributor:
    fullname: AI Astashkina
– ident: 487_CR42
– volume: 7
  start-page: 211
  year: 2006
  ident: 487_CR21
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm1858
  contributor:
    fullname: LG Griffith
– volume: 165
  start-page: 1586
  year: 2016
  ident: 487_CR8
  publication-title: Cell
  doi: 10.1016/j.cell.2016.05.082
  contributor:
    fullname: H Clevers
– volume: 2
  start-page: 192
  year: 2003
  ident: 487_CR57
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd1032
  contributor:
    fullname: H Van De Waterbeemd
– volume: 10
  start-page: 201
  year: 2019
  ident: 487_CR20
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-019-1453-0
  contributor:
    fullname: L Grassi
– volume: 172
  start-page: 38
  year: 2013
  ident: 487_CR1
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2013.07.026
  contributor:
    fullname: AS Abu Lila
– volume: 21
  start-page: 1364
  year: 2015
  ident: 487_CR26
  publication-title: Nat Med
  doi: 10.1038/nm.3973
  contributor:
    fullname: L Huang
– volume: 29
  start-page: 27
  year: 2013
  ident: 487_CR38
  publication-title: Annu Rev Cell Dev Biol
  doi: 10.1146/annurev-cellbio-101512-122340
  contributor:
    fullname: T Mammoto
– volume: 14
  start-page: 20170137
  year: 2017
  ident: 487_CR55
  publication-title: J R Soc Interface
  doi: 10.1098/rsif.2017.0137
  contributor:
    fullname: H-F Tsai
– ident: 487_CR25
– volume: 8
  start-page: 1022
  year: 2016
  ident: 487_CR35
  publication-title: Int J Integr Biol
  doi: 10.1039/C6IB00162A
  contributor:
    fullname: Z Li
– volume: 82
  start-page: 808
  year: 2010
  ident: 487_CR64
  publication-title: Anal Chem
  doi: 10.1021/ac901560w
  contributor:
    fullname: EWK Young
– volume: 9
  start-page: 2026
  year: 2009
  ident: 487_CR54
  publication-title: Lab Chip
  doi: 10.1039/b900912d
  contributor:
    fullname: Y-C Toh
– volume: 21
  start-page: 219
  year: 2019
  ident: 487_CR14
  publication-title: Annu Rev Biomed Eng
  doi: 10.1146/annurev-bioeng-060418-052305
  contributor:
    fullname: A Ehrlich
– volume: 10
  start-page: 3991
  year: 2019
  ident: 487_CR30
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-11867-6
  contributor:
    fullname: M Kim
– volume: 57
  start-page: 2672
  year: 2017
  ident: 487_CR61
  publication-title: J Chem Inf Model
  doi: 10.1021/acs.jcim.7b00244
  contributor:
    fullname: Y Xu
– volume: 4
  start-page: 806
  year: 2004
  ident: 487_CR24
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1456
  contributor:
    fullname: C-H Heldin
SSID ssj0000561889
Score 2.2397077
SecondaryResourceType review_article
Snippet Background Animals have been used for the testing of new drugs and nanoparticles to determine their safety and effectiveness before application in humans....
Background Animals have been used for the testing of new drugs and nanoparticles to determine their safety and effectiveness before application in humans....
SourceID nrf
crossref
springer
SourceType Open Website
Aggregation Database
Publisher
StartPage 327
SubjectTerms Biomedical and Life Sciences
Biomedicine
Review
약학
Title Replacement techniques to reduce animal experiments in drug and nanoparticle development
URI https://link.springer.com/article/10.1007/s40005-020-00487-8
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002587441
Volume 50
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Pharmaceutical Investigation, 2020, 50(3), , pp.327-335
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LSwMxEA62vXjxgYr1UYJ40y3bJLvdHItYq6KnFuopZDdJKcVUttuLv97JPrpIRegph2wGdmaSfJPMfEHoFowcGhmA82o_8lgMUzGCFdJjXDGlfWP6eW3V23s4mrCXaTCt67jzZPfqRjJfqDe1bszBC89FO87rQGQDtcrC09bg6eO1PlpxoDjKH78jEK97QRCQslzmb0G_tqSGTc3WrWi-2QwP0bgq2SlyTBbddRZ3k-9tBsdd_uMIHZTgEw8KbzlGe9qeoClgcHeW7o4J8YbSdYWzJU4dr6vG0s4_YVj9GMAKzy1W6XoGXQpbaSHyLmRiVSchnaLJ8HH8MPLK9xa8hJIg8yhJVAJwLJaahopG0DAeKq6JpISqRHGAc5pCt6EhxFkm8HsJQD5pOIl7MaVnqGmXVp8j7IeSq56UIeE91mcyMoQbLqM4lkGilWyju0rl4qug1RAbAuVcQwI0JHINiaiNbsAqYpHMhWPDdu1sKRapAMz_LADgOZ65NrqvFC7Kebj6R-bFbp9fon2S28ylOl6hZpau9TXAkSzulO7XQY0JGfwAq4PV7w
link.rule.ids 315,783,787,27936,27937,41093,41535,42162,42604,52123,52246
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3PS8MwFA5uHvQiiorzZxBvWuiStGuOQxybbjttsFtIm2SMYSZt9__7krUVUQRPOaR9h_deku-9vPcFoQcwcmxkBM6rwyRgKSzFBHbIgHHFlA6N6fneqsk0Hs7Z6yJaVE1hRV3tXl9J-p26aXZjDl8ELtxxbgcyW2jf8as7xvw56TeZFYeJE__2HYFwPYiiiFTdMr-L-XYitWxuflyK-rNmcIyOKpCI-zurnqA9bU_RArCyy3m7dB5uqFcLXG5w7vhXNZZ29Q6_fZH2F3hlscq3S5hS2EoLEfJOJlZfxUJnaD54mT0Pg-pdhCCjJCoDSjKVAWxKpaaxogkMjMeKayIpoSpTHGCXpjBtaAzxkInCbgbQTBpO0m5K6Tlq243VFwiHseSqK2VMeJf1mEwM4YbLJE1llGklO-ix1o342NFfiIbo2GtSgCaF16RIOuge1CfW2Uo41mo3LjdinQvA5iMBQMzxwXXQU61dUa2X4g-Zl__7_A4dDGeTsRiPpm9X6JB4O7vyxGvULvOtvgEIUaa33mM-AY_Bu-w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwEA9ugvgiiorzM4hvWtYmTdc8DnVsfgwfHOwtpE0yxjAbXff_e2m7TlEEn_KQ5h4ul97vLne_IHQDmxwZycB4tR97YQJHMYY_pBdyFSrtG9Mpeqteh1F_FD6N2fhLF39R7b6-kix7GhxLk83bC2XadeNb6LCG50IfZ4Igv4G2wRVRV9Q3It06y-LwcVy8g0cgdPcYY6TqnPldzDfv1LCZ-XFBWvid3j7aqwAj7pY7fIC2tD1EY8DNLv_tUnu4pmFd4nyOM8fFqrG00w9YtiHwX-KpxSpbTWBKYSstRMulTKw2hUNHaNR7fL_ve9UbCV5KCcs9SlKVAoRKpKaRojEMIY8U10RSQlWqOEAwTWHa0AhiI8P8IAWYJg0nSZBQeoyadm71CcJ-JLkKpIwID8JOKGNDuOEyThLJUq1kC92udSMWJRWGqEmPC00K0KQoNCniFroG9YlZOhWOwdqNk7mYZQJw-kAAKHPccC10t9auqM7O8g-Zp__7_ArtvD30xMtg-HyGdkmxza5S8Rw182ylLwBN5MllYTCf08PAMQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Replacement+techniques+to+reduce+animal+experiments+in+drug+and+nanoparticle+development&rft.jtitle=Journal+of+pharmaceutical+investigation&rft.au=Jin%2C+Ik+Sup&rft.au=Yoon%2C+Moon+Sup&rft.au=Park%2C+Chun-Woong&rft.au=Hong%2C+Jin+Tae&rft.date=2020-05-01&rft.issn=2093-5552&rft.eissn=2093-6214&rft.volume=50&rft.issue=3&rft.spage=327&rft.epage=335&rft_id=info:doi/10.1007%2Fs40005-020-00487-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s40005_020_00487_8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-5552&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-5552&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-5552&client=summon